B1 Non-refereed article in a scientific journal

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Authors: Schimmer Roman R, Kovtonyuk Larisa V, Klemm Nancy, Fullin Jonas, Stolz Sebastian M, Mueller Jan, Caiado Francisco, Kurppa Kari J, Ebert Benjamin L, Manz Markus G, Boettcher Steffen

Publisher: Elsevier

Publication year: 2022

Journal: Blood Advances

Journal name in source: BLOOD ADVANCES

Journal acronym: BLOOD ADV

Volume: 6

Issue: 11

First page : 3201

Last page: 3206

Number of pages: 6

eISSN: 2473-9537

DOI: https://doi.org/10.1182/bloodadvances.2021005859

Web address : https://doi.org/10.1182/bloodadvances.2021005859

Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/176305725